0VH Stock Overview
Engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Ovation Science Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.012 |
| 52 Week High | CA$0.045 |
| 52 Week Low | CA$0.0045 |
| Beta | 0.26 |
| 11 Month Change | 50.00% |
| 3 Month Change | 4.35% |
| 1 Year Change | -40.00% |
| 33 Year Change | -75.76% |
| 5 Year Change | n/a |
| Change since IPO | -95.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0VH | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 33.3% | -1.2% | -0.02% |
| 1Y | -40.0% | -20.1% | 8.2% |
Return vs Industry: 0VH underperformed the German Pharmaceuticals industry which returned -22% over the past year.
Return vs Market: 0VH underperformed the German Market which returned 7.4% over the past year.
Price Volatility
| 0VH volatility | |
|---|---|
| 0VH Average Weekly Movement | 100.4% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 0VH's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 0VH's weekly volatility has increased from 63% to 100% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Terry Howlett | ovationscience.com |
Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. The company sublicenses product formulations through Invisicare, a patented drug delivery technology to produce topical and transdermal cannabis products under the Ovation name. It also offers cannabidiol health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil.
Ovation Science Inc. Fundamentals Summary
| 0VH fundamental statistics | |
|---|---|
| Market cap | €726.43k |
| Earnings (TTM) | -€437.63k |
| Revenue (TTM) | €69.99k |
10.4x
P/S Ratio-1.7x
P/E RatioIs 0VH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0VH income statement (TTM) | |
|---|---|
| Revenue | CA$101.88k |
| Cost of Revenue | CA$38.64k |
| Gross Profit | CA$63.24k |
| Other Expenses | CA$700.23k |
| Earnings | -CA$636.99k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.018 |
| Gross Margin | 62.07% |
| Net Profit Margin | -625.25% |
| Debt/Equity Ratio | -30.4% |
How did 0VH perform over the long term?
See historical performance and comparison